Integrating signals from RTKs to ERK/MAPK

Oncogene

Volumn 26, Issue 22, 2007, Pages 3113-3121

  McKay, M M ^a   Morrison, D K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ERK scaffolds; ERK MA PK; Raf; Ras; RTKs

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAS PROTEIN; SPROUTY PROTEIN;

CELL MEMBRANE; CELL SURFACE; ENZYME ACTIVATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 34248575149     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210394     Document Type: Review

References (75)

1. Abraham D, Podar K, Pacher M, Kubicek M, Welzel N, Hemmings BA et al. (2000). Raf-1-associated protein phosphatase 2Aas a positive regulator of kinase activation. J Biol Chem 275: 22300-22304.
2. Agazie YM, Hayman MJ. (2003). Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol Cell Biol 23: 7875-7886.
3. Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U et al. (1994). Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 13: 1610-1619.
4. Baass PC, Di Guglielmo GM, Authier F, Posner BI, Bergeron JJ. (1995). Compartmentalized signal transduction by receptor tyrosine kinases. Trends Cell Biol 5: 465-470.
5. Bivona TG, Perez De Castro I, Ahearn IM, Grana TM, Chiu VK, Lockyer PJ et al. (2003). Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424: 694-698.
6. Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A et al. (2006). PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 21: 481-493.
7. Bohn G, Allroth A, Brandes G, Thiel J, Glocker E, Schaffer AA et al. (2007). Anovel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 13: 38-45.
8. Boykevisch S, Zhao C, Sondermann H, Philippidou P, Halegoua S, Kuriyan J et al. (2006). Regulation of ras signaling dynamics by sos-mediated positive feedback. Curr Biol 16: 2173-2179.
9. Brose N, Rosenmund C. (2002). Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters. J Cell Sci 115: 4399-4411.
10. Burke P, Schooler K, Wiley HS. (2001). Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol Biol Cell 12: 1897-1910.
11. Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H et al. (2002). Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol 4: 343-350.
12. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D et al. (1999). Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98: 69-80.
13. Dai P, Xiong WC, Mei L. (2006). Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex. J Biol Chem 281: 927-933.
14. Denouel-Galy A, Douville EM, Warne PH, Papin C, Laugier D, Calothy G et al. (1998). Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Curr Biol 8: 46-55.
15. Dhillon AS, Kolch W. (2002). Untying the regulation of the Raf-1 kinase. Arch Biochem Biophys 404: 3-9.
16. Di Guglielmo GM, Baass PC, Ou WJ, Posner BI, Bergeron JJ. (1994). Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J 13: 4269-4277.
17. Downward J. (1996). Control of ras activation. Cancer Surv 27: 87-100.
18. Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC. (1998). RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science 280: 1082-1086.
19. 2+/calmodulin. J Cell Biol 170: 429-441.
20. Freedman TS, Sondermann H, Friedland GD, Kortemme T, Bar-Sagi D, Marqusee S et al. (2006). ARas-induced conformational switch in the Ras activator Son of sevenless. Proc Natl Acad Sci USA 103: 16692-16697.
21. Garnett MJ, Rana S, Paterson H, Barford D, Marais R. (2005). Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Mol Cell 20: 963-969.
22. Goodwin JS, Drake KR, Rogers C, Wright L, Lippincott-Schwartz J, Philips MR et al. (2005). Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway. J Cell Biol 170: 261-272.
23. Hanafusa H, Torii S, Yasunaga T, Matsumoto K, Nishida E. (2004). Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. J Biol Chem 279: 22992-22995.
24. Hanafusa H, Torii S, Yasunaga T, Nishida E. (2002). Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 4: 850-858.
25. Hancock JF, Paterson H, Marshall CJ. (1990). Apolybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63: 133-139.
26. Huang YZ, Zang M, Xiong WC, Luo Z, Mei L. (2003). Erbin suppresses the MAP kinase pathway. J Biol Chem 278: 1108-1114.
27. Ishibe S, Joly D, Liu ZX, Cantley LG. (2004). Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. Mol Cell 16: 257-267.
28. Ishibe S, Joly D, Zhu X, Cantley LG. (2003). Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Mol Cell 12: 1275-1285.
29. Jacobs D, Glossip D, Xing H, Muslin AJ, Kornfeld K. (1999). Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev 13: 163-175.
30. Jaffe AB, Aspenstrom P, Hall A. (2004). Human CNK1 acts as a scaffold protein, linking Rho and Ras signal transduction pathways. Mol Cell Biol 24: 1736-1746.
31. Jaffe AB, Hall A, Schmidt A. (2005). Association of CNK1 with Rho guanine nucleotide exchange factors controls signaling specificity downstream of Rho. Curr Biol 15: 405-412.
32. Jaumot M, Hancock JF. (2001). Protein phosphatases 1 and 2Apromote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20: 3949-3958.
33. Jiang X, Sorkin A. (2002). Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells. Mol Biol Cell 13: 1522-1535.
34. Jura N, Scotto-Lavino E, Sobczyk A, Bar-Sagi D. (2006). Differential modification of Ras proteins by ubiquitination. Mol Cell 21: 679-687.
35. Klinghoffer RA, Kazlauskas A. (1995). Identification of a putative Syp substrate, the PDGF beta receptor. J Biol Chem 270: 22208-22217.
36. Kolch W. (2005). Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6: 827-837.
37. Li W, Han M, Guan K-L. (2000). The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf. Genes Dev 14: 895-900.
38. Mansour SJ, Resing KA, Candi JM, Hermann AS, Gloor JW, Herskind KR et al. (1994). Mitogen-activated protein (MAP) kinase phosphorylation of MAP kinase kinase: determination of phosphorylation sites by mass spectrometry and site-directed mutagenesis. J Biochem 116: 304-314.
39. Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, Pirruccello M et al. (2003). Structural evidence for feedback activation by Ras. GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112: 685-695.
40. Marshall CJ. (1996). Ras effectors. Curr Opin Cell Biol 8: 197-204.
41. Matheny SA, Chen C, Kortum RL, Razidlo GL, Lewis RE, White MA. (2004). Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 427: 256-260.
42. Montagner A, Yart A, Dance M, Perret B, Salles JP, Raynal P. (2005). Anovel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation. J Biol Chem 280: 5350-5360.
43. Mor A, Philips MR. (2006). Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 24: 771-800.
44. Morrison DK, Davis RJ. (2003). Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol 19: 91-118.
45. Muller J, Ory S, Copeland T, Piwnica-Worms H, Morrison DK. (2001). C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol Cell 8: 983-993.
46. Neel BG, Gu H, Pao L. (2003). The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28: 284-293.
47. Ory S, Zhou M, Conrads TP, Veenstra TD, Morrison DK. (2003). Protein phosphatase 2Apositively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol 13: 1356-1364.
48. Pawson T. (2002). Regulation and targets of receptor tyrosine kinases. Eur J Cancer 38: S3-10.
49. Payne DM, Rossomando AJ, Martino P, Erickson AK, Her JH, Shabanowitz J et al. (1991). Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 10: 885-892.
50. Plowman SJ, Hancock JF. (2005). Ras signaling from plasma membrane and endomembrane microdomains. Biochim Biophys Acta 1746: 274-283.
51. Quilliam LA, Khosravi-Far R, Huff SY, Der CJ. (1995). Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins. BioEssays 17: 395-404.
52. Ritt DA, Zhou M, Conrads TP, Veenstra TD, Copeland TD, Morrison DK. (2007). CK2 is a component of the KSR1 scaffold complex that contributes to Raf kinase activation. Curr Biol 17: 179-184.
53. Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA et al. (2007). Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 39: 70-74.
54. Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M et al. (2005). An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307: 1746-1752.
55. Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F. (2006). Aphosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell 22: 217-230.
56. Rushworth LK, Hindley AD, O'Neill E, Kolch W. (2006). Regulation and role of Raf-1/B-Raf heterodimerization. Mol Cell Biol 26: 2262-2272.
57. Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, Sasaki M et al. (2003). Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat Cell Biol 5: 427-432.
58. Schlessinger J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
59. Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, Kuriyan J. (2004). Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell 119: 393-405.
60. Sorkin A, Von Zastrow M. (2002). Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol 3: 600-614.
61. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A et al. (2007). Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39: 75-79.
62. Teis D, Taub N, Kurzbauer R, Hilber D, de Araujo ME, Erlacher M et al. (2006). p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis. J Cell Biol 175: 861-868.
63. Teis D, Wunderlich W, Huber LA. (2002). Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell 3: 803-814.
64. Torii S, Kusakabe M, Yamamoto T, Maekawa M, Nishida E. (2004). Sef is a spatial regulator for Ras/MAP kinase signaling. Dev Cell 7: 33-44.
65. Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K et al. (2001). SPRED is a Sprouty-related suppressor of Ras signalling. Nature 412: 647-651.
66. Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM et al. (2004). Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116: 855-867.
67. Weber CK, Slupsky JR, Kalmes HA, Rapp UR. (2001). Active Ras induces heterodimerization of cRaf and BRaf. Cancer Res 61: 3595-3598.
68. Wellbrock C, Karasarides M, Marais R. (2004). The RAF proteins take centre stage. Nat Rev Mol Cell Biol 5: 875-885.
69. Wunderlich W, Fialka I, Teis D, Alpi A, Pfeifer A, Parton RG et al. (2001). A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment. J Cell Biol 152: 765-776.
70. Yeung K, Janosch P, McFerran B, Rose DW, Mischak H, Sedivy JM et al. (2000). Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the Raf kinase inhibitor protein. Mol Cell Biol 20: 3079-3085.
71. Yu W, Fantl WJ, Harrowe G, Williams LT. (1998). Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK. Curr Biol 8: 56-64.
72. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T et al. (2004). Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell 13: 341-355.
73. Zheng CF, Guan KL. (1994). Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J 13: 1123-1131.
74. Zhou M, Horita DA, Waugh DS, Byrd RA, Morrison DK. (2002). Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR). J Mol Biol 315: 435-446.
75. Ziogas A, Moelling K, Radziwill G. (2005). CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation. J Biol Chem 280: 24205-24211.